Department of General and Pancreatic Surgery, The Verona Pancreas, Institute, University of Verona, Verona, Italy.
Department of Surgery, Pederzoli, Hospital, Peschiera del Garda, Italy.
Ann Surg. 2022 Dec 1;276(6):1029-1038. doi: 10.1097/SLA.0000000000004753. Epub 2021 Jan 15.
The aim of the present study was to critically reappraise the experience at our high-volume institution to obtain new insights for future directions.
The indications, surgical techniques, and perioperative management of pancreatoduodenectomy (PD) have profoundly evolved over the last 20 years.
All consecutive PDs performed during the last 20 years at the Verona Pancreas Institute were divided into four 5-year timeframes and retrospectively analyzed in terms of indications, intraoperative features, and surgical outcomes. Significant milestones were provided to understand practice changes using a before-after analysis method.
The study population consisted of 3000 patients. The median age, ASA ≥ 3 and number of nonbenchmark cases significantly increased over time ( P < 0.005). Pancreatic cancer was the leading indication, representing 60% of patients/year in the last timeframe, 40% of whom received neoadjuvant treatment. Conversely, after the development of International Guidelines, the proportion of resected cystic neoplasms progressively and thoroughly decreased. Given the increased complexity of surgery for pancreatic cancer, the evolution of technologies, surgical techniques, and postoperative management allowed the maintenance of favorable surgical outcomes over time, with a stable 20.0% of patients with a Clavien-Dindo grade ≥ 3, an 11.7% failure to rescue and a 2.3% in-hospital mortality rate. The incidence of postoperative pancreatic fistula, hemorrhage, and delayed gastric emptying was 22.4%, 13.4%, and 12.4%, respectively.
PD significantly evolved in Verona over the past 2 decades. Surgeries of greater complexity are currently performed on increasingly frailer patients, mostly for pancreatic cancer and often after neoadjuvant chemotherapy. However, the progression of all fields of pancreatic surgery, including the expanding use of postoperative pancreatic fistula mitigation strategies, has allowed satisfactory outcomes to be maintained.
本研究旨在批判性地重新评估我们高容量机构的经验,为未来的方向提供新的见解。
过去 20 年来,胰十二指肠切除术(PD)的适应证、手术技术和围手术期管理发生了深刻的变化。
回顾性分析了过去 20 年在维罗纳胰腺研究所进行的所有连续 PD,根据适应证、术中特征和手术结果分为四个 5 年时间框架。使用前后分析方法,提供重要的里程碑以了解实践的变化。
研究人群由 3000 例患者组成。中位年龄、ASA ≥ 3 和非基准病例数随时间显著增加(P < 0.005)。胰腺癌是主要适应证,在最后一个时间框架中占患者/年的 60%,其中 40%接受了新辅助治疗。相反,在国际指南制定后,切除囊性肿瘤的比例逐渐全面下降。鉴于胰腺癌手术的复杂性增加,技术、手术技术和术后管理的发展使手术结果在一段时间内保持良好,稳定的 20.0%患者出现 Clavien-Dindo 分级≥3,11.7%的患者无法挽救,2.3%的患者院内死亡率。术后胰瘘、出血和胃排空延迟的发生率分别为 22.4%、13.4%和 12.4%。
过去 20 年,维罗纳的 PD 发生了重大变化。目前,手术的复杂性增加,患者的身体状况越来越差,主要是治疗胰腺癌,且通常在新辅助化疗后。然而,包括术后胰瘘缓解策略在内的所有胰腺外科领域的进展,使令人满意的结果得以维持。